| ASCO
Initial efficacy and safety of RP1 + nivolumab |
| @dfctankvessel |
04/30/2023 5:31:31 PM |
| It made headlines both sides of the pond. |
| @Lesterk1948 |
04/13/2023 10:58:14 PM |
| (OT) Identification of a viral 5'leader that augments |
| @Rdautoro |
04/07/2023 12:02:26 AM |
| More here https://www.evaluate.com/vantage/articles/news/trial-results/replimune |
| @franck |
03/19/2023 10:32:34 PM |
| Link to webcast https://www.wsw.com/webcast/cc/repl3/register.aspx?conf=cc&page= |
| @amitchate |
12/06/2022 1:09:05 AM |
| An Investor Day set for the 7th at |
| @Yjoshi2994 |
12/06/2022 1:08:11 AM |
| huge: https://nypost.com/2022/09/30/cancerous-tumor-vanishes-with-injection-of-m |
| @jfeinglas |
10/01/2022 5:30:20 AM |
| PR https://www.biospace.com/article/releases/replimune-provides-new-clinical-dat |
| @Harveysch |
04/03/2022 11:15:15 PM |
| Link to webcast https://wsw.com/webcast/cc/repl2/1432638 |
| @guttridgel |
03/21/2022 9:47:11 PM |
| Members of its executive team and KOLs will |
| @bash7 |
03/21/2022 9:46:25 PM |
| The password is: GETICA_220126 https://vimeo.com/674771361 |
| @iggyw1 |
02/18/2022 3:29:47 AM |
| The company will host an investor event in |
| @Jobo1009 |
02/06/2022 12:57:13 AM |
| SITC posters https://ir.replimune.com/static-files/fb937395-5281-41c1-8dba-aca83 |
| @Multicraft |
11/12/2021 4:53:33 PM |
| nice analysis. |
| @Peter |
11/09/2021 12:00:41 AM |
| nice analysis. Yeah most are Trial in |
| @keremkaybal |
10/15/2021 1:25:42 PM |
| Looking forward to seeing these updates from SITC. |
| @Jypokemaster91 |
10/06/2021 1:03:30 AM |
| Looking forward to seeing these updates from SITC. |
| @Pra |
10/02/2021 8:21:29 AM |
| SITC:
Abstract Title: A phase 1 clinical trial of |
| @bobojackson |
10/01/2021 4:21:13 PM |
| Link https://wsw.com/webcast/blair59/panel4/2160224 |
| @shawneebug |
07/13/2021 9:50:30 PM |
| Dr. Coffin, will participate in a panel titled |
| @Londonsmith |
07/11/2021 5:20:14 PM |
| The PR https://www.globenewswire.com/news-release/2021/06/03/2241138/0/en/Replim |
| @humbleinvestor |
06/03/2021 3:49:20 PM |
| Link to the webcast https://wsw.com/webcast/cc/repl/1379538 |
| @fangree |
04/29/2021 12:51:27 AM |
| The company will host an investor event to |
| @MadeMAN |
04/29/2021 12:49:43 AM |
| The posters https://ir.replimune.com/static-files/8ceb7c8e-cf10-4f65-b6ff-30f2aa |
| @Rdautoro |
04/10/2021 7:41:51 PM |
| Dr. Coffin has said that additional data from |
| @randy247 |
03/18/2021 10:21:35 PM |
| Thanks J
I expect to see something significant very soon |
| @claptonrulez |
03/13/2021 12:09:53 AM |
| Why the steep drop today? |
| @ortigoza21 |
03/13/2021 12:07:02 AM |
| AACR https://www.abstractsonline.com/pp8/#!/9325/presentation/4664 https://www.a |
| @vivek |
03/10/2021 11:02:28 PM |
| Why the steep drop today? If this continues, |
| @JoeJoeC |
03/09/2021 12:07:45 AM |
| Yes, this year; |
| @Andres |
03/08/2021 11:25:42 PM |
| So is there anything of interest coming in |
| @Larrynguyen19766 |
03/08/2021 11:14:59 PM |
| JP Morgan webcast https://jpmorgan.metameetings.net/events/healthcare21/sessions |
| @Jay |
01/21/2021 3:22:17 AM |
| SITC posters: |
| @nesset32 |
11/10/2020 9:29:52 PM |
| Updated corporate presentation (RP1 & RP2 data) https://ir.replimune.com/static- |
| @Mdgchar |
10/22/2020 6:11:53 PM |
| SITC
Title: (650) An Open-label, multicenter, Phase 1/2 clinical |
| @nthyaga |
10/14/2020 5:16:51 PM |
| Slides from the IO Summit (the company isn't |
| @clintong |
10/07/2020 10:41:37 PM |
| Slides from the event https://ir.replimune.com/static-files/def39b44-9f58-4fbd-8a36-2f96f628519a |
| @M5cs |
06/24/2020 9:45:38 PM |
| The company will host a conference call to |
| @vikassingh55 |
06/01/2020 5:14:21 PM |
| Looks good https://meetinglibrary.asco.org/record/192615/abstract |
| @Brinx123 |
05/16/2020 1:13:09 AM |
| Initial data on RP2 could be presented at SITC. |
| @baystreetwizard |
05/02/2020 10:55:20 PM |
| Two new trials listed. The first is a |
| @pvpga |
05/02/2020 6:28:22 PM |
| Small number, but encouraging data on another 'armed' |
| @kyle73636 |
04/23/2020 1:09:19 AM |
| An update from last month https://ir.replimune.com/static-files/7aa0f042-b0cf-4f |
| @Markpupilli |
02/20/2020 12:10:25 AM |
| J.P. Morgan webcast https://jpmorgan.metameetings.net/events/hc20/sessions/29931 |
| @Will |
01/26/2020 8:09:48 PM |
| The company has appointed Jean M. Franchi as |
| @bigburt |
12/09/2019 9:06:52 PM |
| Piper Jaffray slides https://ir.replimune.com/static-files/023a7710-3ec0-4f57-a7 |
| @sem |
12/08/2019 6:33:12 PM |
| So the company will raise ~$80M with this |
| @robertbuffet |
11/16/2019 5:49:24 PM |
| The PR https://markets.businessinsider.com/news/stocks/replimune-presents-initia |
| @Franksaran |
11/08/2019 4:34:44 PM |
| The company will host an investor event to |
| @Snooz1011 |
11/03/2019 8:23:18 PM |
| Finally the RP2 trial starts! |
| @nikhild1 |
10/24/2019 8:49:43 PM |